Real-time enrollment status for this arrhythmogenic cardiomyopathy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:39 AM UTC
| NCT Number | NCT06976606 |
| Recruiting Status | Recruiting |
| Condition | Arrhythmogenic Cardiomyopathy |
| Phase | Clinical Trial |
| Target Enrollment | 40 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Lexeo Therapeutics |
| Last Updated on CT.gov | May 16, 2025 (May 16, 2025) |
As of July 13, 2026: Clinical trial NCT06976606 is currently recruiting participants. This clinical trial study for arrhythmogenic cardiomyopathy is actively seeking new participants at 6 locations across the United States. The study is sponsored by Lexeo Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06976606 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06976606 was last updated May 16, 2025 (May 16, 2025). HelloStudys verifies this status automatically.